The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells. - Capaldo,B.; Chan,S.L.; Dunne,M.J.; Stillings,M.R.; Morgan,N.G. (Eur J Pharmacol, 1991)